Results will be presented both as a cost-consequence analysis (presentation of costs and outcomes, including those to practitioners) and as incremental net benefits.
Prof. Pascale Allotey from Monash University, Sunway Campus of Malaysia invited Shenglan Tang to give a presentation on cost control of healthcare in China in the international symposium on universal health coverage held in KL, Malaysia on 3-4 October 2011, upon which this paper was developed.
The presentation of cost-effectiveness acceptability curves are important within this context, demonstrating that there was over an 80% probability that the exercise intervention is a more cost effective option at willingness to pay of £20,000/QALY.
Ideally such an economic evaluation would not only consider the short term effectiveness of DDP but also consider the longer-term economic outcomes, including quality of life that allow for QALY calculation and presentation of cost-effectiveness in terms of incremental cost per QALY gained.
A useful decision-aid, in the form of graphical presentation of costs and effectiveness outcomes, is a 'cost-effectiveness plane' (or 'cost-effectiveness matrix') [ 7].
The presentation of costs and clinical benefits can provide the overall value of multiple interventions through valid approaches like CEAF and EVPI.
Federal agencies should require balanced presentations of costs, risks, and benefits, in a language and format understandable by the average consumer.
As such, we find the presentation of the cost estimates at the level of primary care in this study misleading.
The presentation of incremental cost effectiveness was based on the hierarchy of outcomes, i.e. each treatment option was compared with the next best treatment option in terms of effectiveness.
More transparency is necessary in the presentation of unit costs.
The presentation of unit costs also ensures that estimates can be altered with country-specific data in other settings.
